Quantification of the trabecular bone volume fraction for bone marrow dosimetry in molecular radiotherapy by using a dual-energy (SPECT/)CT
Creators
- 1. Department of Nuclear Medicine, University of Würzburg, Würzburg (Germany)
- 2. Department for Functional Materials in Medicine and Dentistry, University of Würzburg, Würzburg (Germany)
- 3. Department of Diagnostic and Interventional Radiology, University of Würzburg, Würzburg (Germany)
Description
A complete characterization of spongiosa (bone marrow plus trabecular bone) is required to calculate the absorbed dose to active bone marrow. Due to the complex microanatomy, it is necessary to apply non-conventional imaging methods in nuclear medicine. The aim of this study is validating a phantomless quantification method using dual-energy quantitative computed tomography (DEQCT) for the quantification of trabecular bone volume fraction for bone marrow dosimetry in molecular radiotherapy.
First, a phantomless quantification method (mass fraction method) based on x-ray beam and detector sensitivity was validated in an integrated dual energy SPECT/CT and in a dual source computed tomography (DSCT) system for comparison. The validation was performed in a phantom consisting of different water, fat and hydroxyapatite compositions. Moreover, the European spine phantom (ESP) was used to simulate the spine geometry. Bone mineral content (BMC) of the whole vertebra and bone mineral density (BMD) in the spongiosa region of each phantom vertebra were measured using DEQCT and dual energy x-ray absorptiometry (DEXA). Lastly, BMC was measured in a patient using DEQCT and DEXA.
Measured values of hydroxyapatite fraction and nominal values in the homemade phantom showed a good correlation. The relative error remained below 14.2%. Quantification of BMC (in whole vertebra) and BMD (in spongiosa) in the ESP showed a good agreement between measured values and nominal values. The relative error remained between 0.7% and 7.5% for BMCSPECT/CT, 1.1% and 7.7% for BMCDSCT, 5.4% and 32.0 for BMDSPECT/CT, and 59.4% and 10.0% for BMDDSCT. Quantification of BMC in lumbar vertebrae 1 and 2 of a patient showed relative errors of 7.6% and −8.4% between DEXA and DSCT.
Our study shows that DEQCT using a mass fraction method (phantomless) enables quantification of hydroxyapatite in a clinical nuclear medicine setting. An overestimation of the hydroxyapatite volume fraction was observed in all quantified regions, in particular in the spongiosa region of ESP. This result might be related to insufficient information about the x-ray spectra and the detector sensitivity function. (paper)
Availability note (English)
Available from http://dx.doi.org/10.1088/1361-6560/ab4476Additional details
Identifiers
Publishing Information
- Journal Title
- Physics in Medicine and Biology
- Journal Volume
- 64
- Journal Issue
- 20
- Journal Page Range
- [15 p.]
- ISSN
- 0031-9155
- CODEN
- PHMBA7
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 52004065
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ABSORBED RADIATION DOSES; APATITES; BONE MARROW; BONE MINERAL DENSITY; DOSIMETRY; ERRORS; PHANTOMS; RADIOSENSITIVITY; RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TRABECULAR BONE; VERTEBRAE; X RADIATION; X-RAY SPECTRA
- Descriptors DEC
- ANIMAL TISSUES; BODY; BODY COMPOSITION; BONE TISSUES; COMPUTERIZED TOMOGRAPHY; CONNECTIVE TISSUE; DIAGNOSTIC TECHNIQUES; DOSES; ELECTROMAGNETIC RADIATION; EMISSION COMPUTED TOMOGRAPHY; HEMATOPOIETIC SYSTEM; IONIZING RADIATIONS; MEDICINE; MINERALS; MOCKUP; NUCLEAR MEDICINE; ORGANS; PHOSPHATE MINERALS; RADIATION DOSES; RADIATIONS; RADIOLOGY; SENSITIVITY; SKELETON; SPECTRA; STRUCTURAL MODELS; THERAPY; TOMOGRAPHY